Biosimilar Drugs Are Cheaper Than Biologics. Are They Similar Enough to Switch?
(By Michelle Andrews for Kaiser Health News) It took years for Elle Moxley to get a diagnosis that explained her
Read More
Part D/Prescription Drugs
Johnson & Johnson says additional dose boosts Covid vaccine efficacy
(By Matthew Herper for STAT) Johnson & Johnson said Tuesday that a large, global study showed its Covid-19 vaccine is
Read MoreGuard your card: How to protect your Medicare card
(Source – www.medicare.gov/blog) The next Medicare Open Enrollment Period (October 15 – December 7) is coming fast, which means con
Read MoreModerate Democrats sink Pelosi’s aggressive drug pricing bill in key committee vote
(By Rachel Cohrs for STAT) WASHINGTON — House Speaker Nancy Pelosi’s aggressive drug pricing package failed a key committee vote
Read MoreWhat to do if your Medicare drug plan does not cover your prescription
What to do when Medicare does not cover the drug your doctor ordered? It is vital to understand what drug
Read MoreHHS reveals plan to directly negotiate drug prices for Medicare
U.S. Department of Health and Human Services (HHS) unveiled a plan to directly negotiate prices for drugs in Medicare parts
Read MoreFDA vaccine regulators argue against Covid-19 vaccine boosters in new international review
(By Andrew Joseph for STAT) A group of international experts — including, notably, two outgoing Food and Drug Administration vaccine
Read MorePotential Savings for Medicare Part D Enrollees Under Proposals to Add a Hard Cap on Out-of-Pocket Spending
(By Juliette Cubanski, Tricia Neuman, and Anthony Damico for Kaiser Family Foundation published September 10, 2021) Medicare Part D, the
Read MoreOlder people more likely to experience severe breakthrough COVID-19, study finds
(By Erica Carbajal for Becker’s Hospital Review) The median age of fully vaccinated people who developed a severe breakthrough COVID-19 infection
Read MoreOutdated rule increases Medicare’s costs for generic drugs by $26 billion a year
(By Alfred Engelberg for STAT) Public outcry about the shockingly high cost of brand-name drugs and a demand for new
Read More